Piperazines
- (4)
- (1)
- (2)
- (1)
- (4)
- (3)
- (2)
- (5)
- (3)
- (2)
- (5)
- (3)
- (5)
- (4)
- (4)
- (1)
- (5)
- (2)
- (2)
- (2)
- (2)
- (2)
- (1)
- (1)
- (12)
- (1)
- (14)
- (2)
- (3)
- (4)
- (3)
- (9)
- (11)
- (1)
- (2)
- (4)
- (2)
- (1)
- (8)
- (1)
- (5)
- (5)
- (2)
- (4)
- (3)
- (2)
- (4)
- (2)
- (3)
- (3)
- (2)
- (2)
- (5)
- (5)
- (57)
- (5)
- (52)
Filtered Search Results
1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate), 98+%
CAS: 140681-55-6 Molecular Formula: C7H14B2ClF9N2 Molecular Weight (g/mol): 354.26 MDL Number: MFCD00142607 InChI Key: TXRPHPUGYLSHCX-UHFFFAOYSA-N Synonym: selectfluor,1-chloromethyl-4-fluoro-1,4-diazoniabicyclo 2.2.2 octane bis tetrafluoroborate,f-teda-bf4,1-chloromethyl-4-fluoro-1,4-diazabicyclo 2.2.2 octane-1,4-diium tetrafluoroborate,unii-4p1za6r76d,selectfluor fluorinating reagent,f-teda,selectfluor r fluorinating reagent,1-chloromethyl-4-fluoro-1,4-diazoniabicyclo 2.2.2 octane ditetrafluoroborate PubChem CID: 2724933 IUPAC Name: 1-(chloromethyl)-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane;ditetrafluoroborate SMILES: F[B-](F)(F)F.F[B-](F)(F)F.F[N+]12CC[N+](CCl)(CC1)CC2
| PubChem CID | 2724933 |
|---|---|
| CAS | 140681-55-6 |
| Molecular Weight (g/mol) | 354.26 |
| MDL Number | MFCD00142607 |
| SMILES | F[B-](F)(F)F.F[B-](F)(F)F.F[N+]12CC[N+](CCl)(CC1)CC2 |
| Synonym | selectfluor,1-chloromethyl-4-fluoro-1,4-diazoniabicyclo 2.2.2 octane bis tetrafluoroborate,f-teda-bf4,1-chloromethyl-4-fluoro-1,4-diazabicyclo 2.2.2 octane-1,4-diium tetrafluoroborate,unii-4p1za6r76d,selectfluor fluorinating reagent,f-teda,selectfluor r fluorinating reagent,1-chloromethyl-4-fluoro-1,4-diazoniabicyclo 2.2.2 octane ditetrafluoroborate |
| IUPAC Name | 1-(chloromethyl)-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane;ditetrafluoroborate |
| InChI Key | TXRPHPUGYLSHCX-UHFFFAOYSA-N |
| Molecular Formula | C7H14B2ClF9N2 |
Thermo Scientific Chemicals Itraconazole, 99%
CAS: 84625-61-6 Molecular Formula: C35H38Cl2N8O4 Molecular Weight (g/mol): 705.64 MDL Number: MFCD00870168,MFCD00941396 InChI Key: VHVPQPYKVGDNFY-ZPGVKDDISA-N Synonym: itraconazole-d5,itraconazole,oriconazole-d5,triasporin-d5,sporamelt-d5,itrizole-d5,sporanox-d5,+/--4-4-4-4-2r,4s-2,4-dichlorophenyl-2-1h-1,2,4-triazol-1-ylmethyl-1,3-dioxolan-4-yl methoxy phenyl-1-piperazinyl phenyl-2,4-dihydro-2-1-methylpropyl-d5-3h-1,2,4-triazol-3-one,2h5-4-4-4-4-2-1h-1,2,4-triazol-1-yl methyl-2-2,4-dichlorophenyl-1,3-dioxolan-4-yl methoxy phenyl piperazin-1-yl phenyl-1-sec-butyl-1h-1,2,4-triazol-5 4h-one,2-3,3,4,4,4-2 h? butan-2-yl-4-4-4-4-2r,4s-2-2,4-dichlorophenyl-2-1,2,4-triazol-1-ylmethyl-1,3-dioxolan-4-yl methoxy phenyl piperazin-1-yl phenyl-1,2,4-triazol-3-one PubChem CID: 45039617 IUPAC Name: 4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-(3,3,4,4,4-pentadeuteriobutan-2-yl)-1,2,4-triazol-3-one SMILES: CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
| PubChem CID | 45039617 |
|---|---|
| CAS | 84625-61-6 |
| Molecular Weight (g/mol) | 705.64 |
| MDL Number | MFCD00870168,MFCD00941396 |
| SMILES | CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1 |
| Synonym | itraconazole-d5,itraconazole,oriconazole-d5,triasporin-d5,sporamelt-d5,itrizole-d5,sporanox-d5,+/--4-4-4-4-2r,4s-2,4-dichlorophenyl-2-1h-1,2,4-triazol-1-ylmethyl-1,3-dioxolan-4-yl methoxy phenyl-1-piperazinyl phenyl-2,4-dihydro-2-1-methylpropyl-d5-3h-1,2,4-triazol-3-one,2h5-4-4-4-4-2-1h-1,2,4-triazol-1-yl methyl-2-2,4-dichlorophenyl-1,3-dioxolan-4-yl methoxy phenyl piperazin-1-yl phenyl-1-sec-butyl-1h-1,2,4-triazol-5 4h-one,2-3,3,4,4,4-2 h? butan-2-yl-4-4-4-4-2r,4s-2-2,4-dichlorophenyl-2-1,2,4-triazol-1-ylmethyl-1,3-dioxolan-4-yl methoxy phenyl piperazin-1-yl phenyl-1,2,4-triazol-3-one |
| IUPAC Name | 4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-(3,3,4,4,4-pentadeuteriobutan-2-yl)-1,2,4-triazol-3-one |
| InChI Key | VHVPQPYKVGDNFY-ZPGVKDDISA-N |
| Molecular Formula | C35H38Cl2N8O4 |
GLX351322, MedChemExpress
MedChemExpress GLX351322 is an inhibitor of NADPH oxidase 4 (Nox4), and inhibits hydrogen peroxide production from NOX4-overexpressing cells with an IC50 of 5 μM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 431.51 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | GLX351322 |
| Grade | Research |
| SMILES | O=C(OCC)C1=C(SC2=C1CCC2)NC(CN3CCN(CC3)C(C4=CC=CO4)=O)=O |
| For Use With (Application) | Metabolism-sugar/lipid metabolism |
| Percent Purity | 99.94% |
| CAS | 835598-94-2 |
| Solubility Information | DMSO : 20 mg/mL (46.35 mM; Need ultrasonic) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C21H25N3O5S |
| Formula Weight | 431.51 |
Aspartyl-alanyl-diketopiperazine, MedChemExpress
MedChemExpress Aspartyl-alanyl-diketopiperazine (DA-DKP) is an immunomodulatory molecule generated by cleavage and cyclization from the N-terminus of human albumin and can modulate the inflammatory immune response through a molecular pathway implicated in T- lymphocyte anergy.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 186.17 |
|---|---|
| Color | Off-White |
| Physical Form | Solid |
| Chemical Name or Material | Aspartyl-alanyl-diketopiperazine |
| Grade | Research |
| SMILES | O=C(O)C[C@@H](C(N[C@H]1C)=O)NC1=O |
| For Use With (Application) | Neuroscience-Neuromodulation |
| Percent Purity | 99.44% |
| CAS | 110954-19-3 |
| Solubility Information | DMSO : 125 mg/mL (671.43 mM; Need ultrasonic) |
| Synonym | DA-DKP |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C7H10N2O4 |
| Formula Weight | 186.17 |
BIBF 1202, MedChemExpress
MedChemExpress BIBF 1202 is the carboxylate metabolite of BIBF 1120 which inhibits VEGFR2 kinase with an IC50 of 62 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 525.6 |
|---|---|
| Color | Yellow |
| Physical Form | Solid |
| Chemical Name or Material | BIBF 1202 |
| Grade | Research |
| SMILES | O=C(C1=CC(NC/2=O)=C(C=C1)C2=C(NC3=CC=C(N(C)C(CN4CCN(C)CC4)=O)C=C3)/C5=CC=CC=C5)O |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 96.62% |
| CAS | 894783-71-2 |
| Solubility Information | DMSO : ≥ 45 mg/mL (85.62 mM) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C30H31N5O4 |
| Formula Weight | 525.6 |
(S)-ML753286, MedChemExpress
MedChemExpress (S)-ML753286 is a breast cancer resistance protein (BCRP) inhibitor with an IC50 of 0.6 μM on BCRP efflux transporter.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 355.43 |
|---|---|
| Color | Off-White |
| Physical Form | Solid |
| Chemical Name or Material | (S)-ML753286 |
| Grade | Research |
| SMILES | COC1=CC=C2C(NC3=C2C[C@]4([H])N(C([C@H](C)NC4=O)=O)[C@H]3CC(C)C)=C1 |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 98.62% |
| CAS | 1699720-85-8 |
| Solubility Information | DMSO : ≥ 50 mg/mL (140.67 mM) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C20H25N3O3 |
| Formula Weight | 355.43 |
Plinabulin, MedChemExpress
MedChemExpress Plinabulin (NPI-2358) is a vascular disrupting agen (VDA) against tubulin-depolymerizing with an IC50 of 9.8 nM against HT-29 cells. Plinabulin binds the colchicine binding site of β-tubulin preventing polymerization and has potent inhibitory to tumor cells.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 336.39 |
|---|---|
| Color | Yellow |
| Physical Form | Solid |
| Chemical Name or Material | Plinabulin |
| Grade | Research |
| SMILES | O=C(N/C1=C\C2=C(NC=N2)C(C)(C)C)/C(NC1=O)=C/C3=CC=CC=C3 |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 98.0% |
| CAS | 714272-27-2 |
| Solubility Information | DMSO : 50 mg/mL (148.64 mM; Need ultrasonic) |
| Synonym | NPI-2358 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C19H20N4O2 |
| Formula Weight | 336.39 |
Tadalafil, MedChemExpress
MedChemExpress Tadalafil (IC-351) is a PDE5 inhibitor with an IC50 value of 1.8 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 389.4 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Tadalafil |
| Grade | Research |
| SMILES | O=C([C@@]1([H])CC2=C([C@@H](C3=CC=C(OCO4)C4=C3)N15)NC6=C2C=CC=C6)N(C)CC5=O |
| For Use With (Application) | COVID-19-immunoregulation |
| Percent Purity | 99.85% |
| CAS | 171596-29-5 |
| Solubility Information | DMSO : ≥ 52 mg/mL (133.54 mM) |
| Synonym | IC-351 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C22H19N3O4 |
| Formula Weight | 389.4 |
Nortadalafil, MedChemExpress
MedChemExpress Nortadalafil is demethyl Tadalafil, which is a PDE5 inhibitor, currently marketed in pill form for treating erectile dysfunction (ED) under the name Cialis; and under the name Adcirca for the treatment of pulmonary arterial hypertension.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 375.38 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Nortadalafil |
| Grade | Research |
| SMILES | O=C1NCC(N([C@@H]1C2)[C@H](C3=CC=C(OCO4)C4=C3)C5=C2C6=C(N5)C=CC=C6)=O |
| For Use With (Application) | COVID-19-immunoregulation |
| Percent Purity | 99.77% |
| CAS | 171596-36-4 |
| Solubility Information | DMSO : 50 mg/mL (133.20 mM; Need ultrasonic) |
| Health Hazard 1 | H302∣H315∣H319∣H335 |
| Synonym | Demethyl Tadalafil |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C21H17N3O4 |
| Formula Weight | 375.38 |
Golidocitinib, MedChemExpress
MedChemExpress Golidocitinib (AZD4205) is a selective JAK1 inhibitor, with an IC50 of 73 nM, weakly inhibits JAK2 (IC50>14.7 μM), and shows little inhibition on JAK3 (IC50>30 μM).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 489.57 |
|---|---|
| Color | Yellow |
| Physical Form | Solid |
| Chemical Name or Material | Golidocitinib |
| Grade | Research |
| SMILES | C[C@@H](N1CCN(C)CC1)C(NC2=C3C(C(C4=NC(NC5=CN(C)N=C5OC)=NC=C4)=CN3)=CC=C2)=O |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 98.0% |
| CAS | 2091134-68-6 |
| Solubility Information | DMSO : 250 mg/mL (510.65 mM; Need ultrasonic) |
| Synonym | AZD4205 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C25H31N9O2 |
| Formula Weight | 489.57 |
Ko 143, MedChemExpress
MedChemExpress Ko 143 is a potent and selective ATP-binding cassette subfamily G member 2 (ABCG2/BCRP) inhibitor. Ko 143 displays >200-fold selectivity over P-gp and MRP-1 transporters.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 469.57 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Ko 143 |
| Grade | Research |
| SMILES | O=C1N2[C@]([H])(C3=C(C[C@]2(C(N[C@H]1CCC(OC(C)(C)C)=O)=O)[H])C4=CC=C(OC)C=C4N3)CC(C)C |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 98.74% |
| CAS | 461054-93-3 |
| Solubility Information | DMSO : 100 mg/mL (212.96 mM; Need ultrasonic) |
| Health Hazard 1 | H315∣H319∣H335 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C26H35N3O5 |
| Formula Weight | 469.57 |
ML348, MedChemExpress
MedChemExpress ML348 (GNF-Pf-1127) is a selective and reversible acyl-protein thioesterase 1 (APT1)/lysophospholipase 1 (LYPLA1) inhibitor with an IC50 of 210 nM, and barely inhibits LYPLA2.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 415.79 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | ML348 |
| Grade | Research |
| SMILES | O=C(NC1=CC(C(F)(F)F)=CC=C1Cl)CN2CCN(C(C3=CC=CO3)=O)CC2 |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 99.96% |
| CAS | 899713-86-1 |
| Solubility Information | DMSO : 25 mg/mL (60.13 mM; Need ultrasonic) |
| Synonym | GNF-Pf-1127 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C18H17ClF3N3O3 |
| Formula Weight | 415.79 |
p53 and MDM2 proteins-interaction-inhibitor (chiral), MedChemExpress
MedChemExpress p53 and MDM2 proteins-interaction-inhibitor (chiral) (Compound 32) is an inhibitor of the interaction between p53 and MDM2 proteins.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 734.75 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | p53 and MDM2 proteins-interaction-inhibitor (chiral) |
| Grade | Research |
| SMILES | O=C(N1CCN(CC(N2CCOCC2)=O)CC1)N3[C@](C)(C4=CC=C(Cl)C=C4)[C@](C)(C5=CC=C(Cl)C=C5)N=C3C6=CC=C(C(C)(C)C)C=C6OCC |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 98.73% |
| CAS | 939981-37-0 |
| Solubility Information | DMSO : 50 mg/mL (68.05 mM; Need ultrasonic) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C40H49Cl2N5O4 |
| Formula Weight | 734.75 |
p53 and MDM2 proteins-interaction-inhibitor dihydrochloride, MedChemExpress
MedChemExpress p53 and MDM2 proteins-interaction-inhibitor dihydrochloride is an inhibitor of the interaction between p53 and MDM2 proteins.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 807.68 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | p53 and MDM2 proteins-interaction-inhibitor dihydrochloride |
| Grade | Research |
| SMILES | O=C(N1CCN(CC(N2CCOCC2)=O)CC1)N3[C@](C)(C4=CC=C(Cl)C=C4)[C@](C)(C5=CC=C(Cl)C=C5)N=C3C6=CC=C(C(C)(C)C)C=C6OCC.Cl.Cl |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 99.79% |
| Solubility Information | DMSO : 100 mg/mL (123.81 mM; Need ultrasonic) |
| Purity Grade Notes | Research |
| Recommended Storage | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Shelf Life | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Molecular Formula | C40H51Cl4N5O4 |
| Formula Weight | 807.68 |
Indinavir sulfate, MedChemExpress
MedChemExpress Indinavir sulfate (MK-639) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir sulfate exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir sulfate is also a SARS-CoV 3CLpro inhibitor.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 711.87 |
|---|---|
| Color | White |
| Physical Form | Powder |
| Chemical Name or Material | Indinavir sulfate |
| Grade | Research |
| SMILES | O=C([C@@H](C[C@H](O)CN(CCN(CC1=CN=CC=C1)C2)[C@@H]2C(NC(C)(C)C)=O)CC3=CC=CC=C3)N[C@H]4C(C=CC=C5)=C5C[C@H]4O.O=S(O)(O)=O |
| For Use With (Application) | COVID-19-anti-virus |
| Percent Purity | 99.62% |
| CAS | 157810-81-6 |
| Solubility Information | DMSO : ≥ 100 mg/mL (140.48 mM) ∣H2O : 50 mg/mL (70.24 mM; Need ultrasonic) |
| Synonym | MK-639 L735524 |
| Purity Grade Notes | Research |
| Recommended Storage | -20°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Shelf Life | -20°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Molecular Formula | C36H49N5O8S |
| Formula Weight | 711.87 |